Canada Gazette, Part I, Volume 158, Number 11: GOVERNMENT NOTICES
March 16, 2024
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Federal Environmental Quality Guidelines for triclocarban
Whereas the Minister of the Environment issues the environmental quality guidelines for the purpose of carrying out the Minister’s mandate related to preserving the quality of the environment;
Whereas the guidelines relate to the environment pursuant to paragraph 54(2)(a) of the Canadian Environmental Protection Act, 1999;
And whereas the Minister of the Environment has consulted provincial and territorial governments and the members of the National Advisory Committee who are representatives of indigenous governments in accordance with subsection 54(3) of the Act;
Notice is hereby given that the Federal Environmental Quality Guidelines for triclocarban are available on the Canada.ca (Chemical substances) website.
Jacqueline Gonçalves
Director General
Science and Risk Assessment Directorate
On behalf of the Minister of the Environment
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Interim Order Modifying the Operation of the Heavy-duty Vehicle and Engine Greenhouse Gas Emission Regulations (Trailer Standards)
Whereas certain provisions of part 1037 of Title 40, chapter I, subchapter U of the Code of Federal Regulations of the United States correspond to certain provisions of the Heavy-duty Vehicle and Engine Greenhouse Gas Emission Regulations footnote a;
And whereas certain provisions of those Regulations are inconsistent with certain provisions of that part because of the decision issued by the United States Court of Appeals for the District of Columbia Circuit, on November 12, 2021, in Truck Trailer Manufacturers Association, Inc. v. Environmental Protection Agency, et al. (Case No. 16-1430) to vacate all portions of the final rule of the United States Environmental Protection Agency published in October 2016 in volume 81 of the Federal Register of the United States, at page 73,478, that apply to trailers, including the portion that enacted section 1037.107, which sets out the emission standards for trailers;
Therefore, the Minister of the Environment makes the annexed Interim Order Modifying the Operation of the Heavy-duty Vehicle and Engine Greenhouse Gas Emission Regulations (Trailer Standards) under subsection 163(1) of the Canadian Environmental Protection Act, 1999 footnote b.
Gatineau, February 19, 2024
Steven Guilbeault
Minister of the Environment
Interim Order Modifying the Operation of the Heavy-duty Vehicle and Engine Greenhouse Gas Emission Regulations (Trailer Standards)
January 1, 2020
1 Despite any provision of the Heavy-duty Vehicle and Engine Greenhouse Gas Emission Regulations, those Regulations do not apply to trailers whose manufacture is completed on or after January 1, 2020.
EXPLANATORY NOTE
(This note is not part of the Interim Order.)
The Interim Order Modifying the Operation of the Heavy-duty Vehicle and Engine Greenhouse Gas Emission Regulations (Trailer Standards) was made by the Minister of the Environment on February 19, 2024. The Interim Order applies to trailers only and temporarily suspends the application of the trailer provisions of the Heavy-duty Vehicle and Engine Greenhouse Gas Emission Regulations. Upon approval by the Governor in Council, and in accordance with subsection 163(5) of the Canadian Environmental Protection Act, 1999, the Interim Order will cease to have effect one year after it is made, or the day it is repealed, or the day on which the regulation is amended or repealed to give effect to the order, whichever is earlier.
DEPARTMENT OF THE ENVIRONMENT
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Ministerial Condition No. 21722
Ministerial condition
(Paragraph 109(1)(a) of the Canadian Environmental Protection Act, 1999)
Whereas the Minister of the Environment and the Minister of Health (the ministers) have assessed information pertaining to the living organism live vaccinia virus Acambis clone 2000;
And whereas the ministers suspect that the living organism is toxic or capable of becoming toxic within the meaning of section 64 of the Canadian Environmental Protection Act, 1999 (the Act),
The Minister of the Environment, pursuant to paragraph 109(1)(a) of the Act, hereby permits the manufacture or import of the living organism subject to the conditions of the following annex.
Marc D’Iorio
Assistant Deputy Minister
Science and Technology Branch
On behalf of the Minister of the Environment
ANNEX
Conditions
(Paragraph 109(1)(a) of the Canadian Environmental Protection Act, 1999)
1. The following definitions apply in these ministerial conditions:
- “Canadian Biosafety Standard”
- means the document entitled Canadian Biosafety Standard, 2nd Edition, published in 2015, developed by the Public Health Agency of Canada and the Canadian Food Inspection Agency, as amended from time to time;
- “contained facility”
- means an enclosed building with walls, floor and ceiling, or an area within such a building, where the containment is in accordance with the physical and operational requirements of a level set out in either the Canadian Biosafety Standard or Appendix K of the Guidelines for Research Involving Recombinant DNA Molecules (NIH Guidelines) June 1994, published in the Federal Register by the U.S. Department of Health and Human Services, 59 FR 34472 (July 5, 1994), as amended from time to time, and which are required based on the risk group classification of the living organism;
- “engineered hazardous waste landfill facility”
- means a facility that is part of an overall integrated hazardous waste management system where wastes that do not require additional treatment or processing are sent and where hazardous materials are confined or controlled for the duration of their effective contaminating lifespan;
- “living organism”
- means the living organism live vaccinia virus Acambis clone 2000;
- “notifier”
- means the person who has, on December 8, 2023, provided to the Minister of the Environment the prescribed information concerning the living organism, in accordance with subsection 106(1) of the Canadian Environmental Protection Act, 1999; and
- “waste”
- means any solid or liquid material generated by a facility for disposal and may include the effluents that result from rinsing equipment or vessels used for the living organism, and may also include disposable vessels used for the living organism, any spillage that contains the living organism, the process effluents that contain the living organism, and any residual quantity of the living organism in any equipment or vessel.
2. The notifier may manufacture or import the living organism subject to the present ministerial conditions.
3. The present ministerial conditions do not apply in relation to the living organism if a licence has been issued to the notifier under the Human Pathogens and Toxins Act to conduct controlled activities with the living organism.
Restrictions
4. (1) The notifier may only manufacture or import the living organism if the following conditions are met:
- (a) it is imported to a contained facility that meets the containment level requirements for Risk Group 2 organisms or, if the living organism is classified in a different risk group, the containment level for that risk group;
- (b) it is manufactured in a contained facility that meets the containment level requirements for Risk Group 2 organisms or, if the living organism is classified in a different risk group, the containment level for that risk group; and
- (c) it is only transferred to a facility with procedures in place to mitigate spills and prevent release.
(2) Despite subsection (1), if the living organism is imported as a component of a vaccine product, the notifier may import or transfer it to a facility with procedures in place to mitigate spills and prevent release.
5. At least 120 days prior to beginning manufacturing the living organism or a vaccine containing the living organism in Canada, the notifier shall inform the Minister of the Environment, in writing, and provide the following information:
- (a) the identification of location of manufacture in Canada;
- (b) a description of any recommended storage and disposal procedures specific to the Canadian manufacturing facility;
- (c) an estimation of the quantity of the living organism that will be manufactured in or imported into Canada, as the case may be, during the first 12 months, and the expected maximum quantity manufactured or imported in any 12-month period during the first three years;
- (d) a description of the equipment and methods of manufacture and of quality control and quality assurance procedures specific to the Canadian manufacturing facility;
- (e) a description of the location of the manufacturing facility in Canada (e.g. surrounding area, proximity to populated areas) as well as containment measures in place;
- (f) a description of the nature of potential releases of the living organism from the manufacturing facility in Canada or from the facility to which the living organism will be imported, as the case may be, and the procedures to control releases; and
- (g) a description of the procedures for the treatment and disposal of wastes containing the living organism from the manufacturing facility in Canada.
6. The notifier must provide the following instructions, in writing, to any person to whom they transfer physical possession or control of the living organism:
- (a) administration of the vaccine containing the living organism must be performed by trained personnel;
- (b) the vaccine containing the living organism must only be administered by the percutaneous route (scarification);
- (c) the vaccination site must be covered with a gauze bandage, using first aid adhesive tape to keep it in place, until the lesion heals;
- (d) if the vaccine recipient is involved in direct patient care, the vaccination site must be covered with gauze and then with a semipermeable (semi-occlusive) dressing as an additional barrier that allows for the passage of air but does not allow for the passage of fluids until the lesion heals;
- (e) vaccine recipients must be advised to wash their hands with soap and warm water or with alcohol-based hand rubs such as gels or foams after direct contact with the vaccination site, the bandage, or clothes, towels or sheets that might be contaminated with the living organism from the vaccination site; and
- (f) specimens or samples collected from vaccine recipients must be handled in accordance with the Canadian Biosafety Standard.
Handling and disposal
7. When the living organism is under the physical possession or control of the notifier, the notifier must
- (a) not release the living organism or waste containing it into the environment;
- (b) decontaminate all surfaces that may directly come into contact with the living organism with an effective antiviral agent;
- (c) decontaminate liquids containing the living organism prior to release to sanitary sewers;
- (d) collect waste containing the living organism in biohazard containers and destroy or dispose of it in the following manner:
- (i) materials that come into contact with the living organism, including waste, must be disinfected by sterilization or autoclaved prior to being recycled, reused, disposed of, or destroyed, and
- (ii) once disinfected, waste must be disposed of as biohazardous or infectious medical waste.
Environmental release
8. When the living organism or waste containing it is under the physical possession or control of the notifier and any release of the living organism or waste to the environment occurs, the notifier must immediately take all measures necessary to prevent any further release and to limit the dispersion of any release. Furthermore, the notifier must, as soon as possible in the circumstances, inform the Minister of the Environment by contacting an enforcement officer designated under the Canadian Environmental Protection Act, 1999.
Other requirements
9. The notifier shall, prior to transferring the physical possession or control of the living organism or waste containing it to any person,
- (a) inform the person, in writing, of the terms of the present ministerial conditions; and
- (b) obtain, prior to the first transfer of the living organism or waste, written confirmation from this person that they were informed of the terms of the present ministerial conditions and agree to comply with paragraph 4(c) and sections 5 to 8 of the present ministerial conditions.
Record-keeping requirements
10. (1) The notifier shall maintain electronic or paper records, with any documentation supporting the validity of the information contained in these records, indicating
- (a) the use of the living organism;
- (b) the quantity of the living organism that the notifier manufactures, imports, purchases, distributes, sells and uses;
- (c) the risk group classification of the living organism;
- (d) the containment level of the facility where the living organism was imported or manufactured;
- (e) the name and address of each person to whom the notifier transfers the physical possession or control of the living organism;
- (f) the name and address of each person in Canada who disposed of the living organism or of waste on behalf of the notifier, the method used to do so and the quantities of the living organism or waste shipped to that person; and
- (g) the written confirmation referred to in paragraph 9(b).
(2) When the notifier learns of a change to the address referred to in paragraphs (1)(e) and (1)(f), the notifier must update the electronic or paper records mentioned in subsection (1) accordingly within 30 days after learning of the change.
(3) The notifier shall create the electronic or paper records mentioned in subsection (1) no later than 30 days after the date the information or documents become available.
(4) The notifier shall maintain the electronic or paper records mentioned in subsection (1)
- (a) in English, French, or both languages; and
- (b) at the notifier’s principal place of business in Canada, or at the principal place of business in Canada of their representative, for a period of at least five years after they are made.
(5) Any records mentioned in subsection (1) that are kept electronically must be in an electronically readable format.
Coming into force
11. The present ministerial conditions come into force on February 27, 2024.
DEPARTMENT OF THE ENVIRONMENT DEPARTMENT OF HEALTH
CANADIAN ENVIRONMENTAL PROTECTION ACT, 1999
Publication after assessment of 27 Low Boiling Point Naphthas Group substances specified on the Domestic Substances List (section 77 of the Canadian Environmental Protection Act, 1999)
Whereas a summary of the draft assessment conducted on naphtha (petroleum), light alkylate; naphtha (petroleum), solvent-refined heavy; and solvent naphtha (petroleum), light aromatic, hydrotreated, pursuant to paragraphs 68(b) and (c) of the Act is annexed hereby;
And whereas it is proposed to conclude that the nine C9–C14 hydrocarbon solvents (subgroup 1), the one C9 aromatic solvent (subgroup 2) and the seven C6–C9 aliphatic solvents (subgroup 3) meet one or more of the criteria set out in section 64 of the Act;
Notice therefore is hereby given that the Minister of the Environment and the Minister of Health (the ministers) propose to recommend to Her Excellency the Governor in Council that these 17 substances be added to Part 2 of Schedule 1 to the Act;
Notice is furthermore given that the ministers have released a risk management scope document for these substances to initiate discussions with stakeholders on the development of risk management options.
And whereas it is proposed to conclude that the remaining ten substances with no identified uses in products available to consumers (subgroup 4) do not meet any of the criteria set out in section 64 of the Act,
Notice is further given that the ministers propose to take no further action on the remaining ten substances at this time.
Public comment period
Any person may, within 60 days after publication of this notice, file with the Minister of the Environment written comments on the measure the ministers propose to take and on the scientific considerations on the basis of which the measure is proposed. More information regarding the scientific considerations may be obtained from the Canada.ca (Chemical Substances) website. All comments must cite the Canada Gazette, Part I, and the date of publication of this notice and be addressed to the Executive Director, Substance Prioritization, Assessment, and Coordination Division, Department of the Environment, Gatineau, Quebec K1A 0H3, by email to substances@ec.gc.ca or by using the online reporting system available through Environment and Climate Change Canada’s Single Window.
In accordance with section 313 of the Canadian Environmental Protection Act, 1999, any person who provides information in response to this notice may submit with the information a request that it be treated as confidential.
Jacqueline Gonçalves
Director General
Science Reporting and Assessment Directorate
On behalf of the Minister of the Environment
Cécile Siewe
Director General
Industrial Sectors and Chemicals Directorate
On behalf of the Minister of the Environment
Greg Carreau
Director General
Safe Environments Directorate
On behalf of the Minister of Health
ANNEX
Summary of the draft assessment of the Low Boiling Point Naphthas Group
Pursuant to section 68 of the Canadian Environmental Protection Act, 1999 (CEPA), the Minister of the Environment and the Minister of Health have conducted an assessment of 27 substances referred to collectively under the Chemicals Management Plan as the Low Boiling Point Naphthas (LBPNs) Group. The Chemical Abstracts Service Registry Numbers (CAS RNsfootnote 1), the Domestic Substances List (DSL) names, and the subgrouping of these substances are listed in the table below.
CAS RN | DSL name | Subgrouping (number) |
---|---|---|
8030-30-6 table 1 note a | Naphtha | C9–C14 hydrocarbon solvents (1) |
8032-32-4 table 1 note a | Ligroine | C9–C14 hydrocarbon solvents (1) |
8052-41-3 table 1 note a | Stoddard solvent | C9–C14 hydrocarbon solvents (1) |
64475-85-0 table 1 note a | Petroleum spirits | C9–C14 hydrocarbon solvents (1) |
64741-41-9 table 1 note a | Naphtha (petroleum), heavy straight-run | C9–C14 hydrocarbon solvents (1) |
64741-65-7 table 1 note a | Naphtha (petroleum), heavy alkylate | C9–C14 hydrocarbon solvents (1) |
64741-66-8 table 1 note a | Naphtha (petroleum), light alkylate | C6–C9 aliphatic solvents (3) |
64741-68-0 table 1 note a | Naphtha (petroleum), heavy catalytic reformed | No consumer use identified (4) |
64741-84-0 table 1 note a | Naphtha (petroleum), solvent-refined light | C6–C9 aliphatic solvents (3) |
64741-92-0 table 1 note a | Naphtha (petroleum), solvent-refined heavy | No consumer use identified (4) |
64741-98-6 table 1 note a | Extracts (petroleum), heavy naphtha solvent | No consumer use identified (4) |
64742-48-9 table 1 note a | Naphtha (petroleum), hydrotreated heavy | C9–C14 hydrocarbon solvents (1) |
64742-49-0 table 1 note a | Naphtha (petroleum), hydrotreated light | C6–C9 aliphatic solvents (3) |
64742-82-1 table 1 note a | Naphtha (petroleum), hydrodesulfurized heavy | C9–C14 hydrocarbon solvents (1) |
64742-88-7 table 1 note a | Solvent naphtha (petroleum), medium aliph. | C9–C14 hydrocarbon solvents (1) |
64742-89-8 table 1 note a | Solvent naphtha (petroleum), light aliph. | C6–C9 aliphatic solvents (3) |
64742-95-6 table 1 note a | Solvent naphtha (petroleum), light arom. | C9 aromatic solvents (2) |
68333-81-3 table 1 note a | Alkanes, C4–12 | No consumer use identified (4) |
68410-97-9 table 1 note a | Distillates (petroleum), light distillate hydrotreating process, low-boiling | C6–C9 aliphatic solvents (3) |
68512-78-7 table 1 note a | Solvent naphtha (petroleum), light arom., hydrotreated | No consumer use identified (4) |
68513-03-1 table 1 note a | Naphtha (petroleum), light catalytic reformed, arom.-free | No consumer use identified (4) |
68553-14-0 table 1 note a | Hydrocarbons, C8–11 | No consumer use identified (4) |
68603-08-7 table 1 note a | Naphtha (petroleum), arom.-contg. | No consumer use identified (4) |
68647-60-9 table 1 note a | Hydrocarbons, C>4 | C6–C9 aliphatic solvents (3) |
68920-06-9 table 1 note a | Hydrocarbons, C7–9 | No consumer use identified (4) |
70693-06-0 table 1 note a | Aromatic hydrocarbons, C9–11 | No consumer use identified (4) |
426260-76-6 table 1 note a | Heptane, branched, cyclic and linear | C6–C9 aliphatic solvents (3) |
Table 1 note(s)
|
For the purposes of the human health assessment, the LBPN substances in this assessment were divided into four subgroups: C9–C14 hydrocarbon solvents (subgroup 1), C9 aromatic hydrocarbon solvents (subgroup 2), the C6–C9 aliphatic hydrocarbon solvents (subgroup 3), and the LBPNs with no identified uses in products available to consumers (subgroup 4). The primary basis for the subgroups was the differences in health effects, carbon ranges for the hydrocarbon components, aromatic content, and potential uses in products available to consumers. Within each subgroup, the CAS RNs are assumed to be interchangeable with respect to their use in categories of products available to consumers.
The 27 LBPNs in this assessment are complex and highly variable combinations of hydrocarbons produced by the distillation of crude oil, followed by the fractionation of the resultant hydrocarbon streams by boiling range. They contain straight and branched chain alkanes (that is paraffins and isoparaffins), cycloalkanes (also known as cycloparaffins), alkenes (also known as olefins), and aromatic hydrocarbons, predominantly in the carbon range of C4 to C14.
The 27 LBPN substances in this assessment may be used at the refinery where they are produced; blended into substances leaving the refinery under different CAS RNs; or transported by truck or train to other petroleum or non-petroleum sector facilities for use as feedstocks or to be blended with other feedstocks, resulting in a new substance with a new CAS RN. The exposures and risks associated with petroleum industry uses of the 27 LPBN substances are considered to be similar to those of the site-restricted and industry-restricted LBPNs for which risk assessment activities are considered to have already taken place under CEPA and are not considered further in this assessment. Several of the 27 LBPN substances are also identified as being used in non-petroleum industries as solvents and are present in products available to consumers, including in cosmetics, automotive products, paints and coatings, adhesives and sealants, household cleaning products, and as formulants in pest control products. Some may also be used in the manufacture of food packaging materials and in incidental additives used in food processing establishments.
Since the aromatic content of the LBPNs in many commercial or industrial uses is unknown, aromatic contents ranging from 0% to 100% by weight were considered in the ecological assessment. Empirical aquatic toxicity data for LBPNs were comparable with modelled toxicity values. However, the predicted no-effect concentrations were determined on the basis of modelled aquatic toxicity data, which made it possible to estimate toxicity in the most sensitive species for LBPNs with a range of aromatic contents, while taking into consideration the compositional changes after wastewater treatment.
Predicted environmental concentrations of LBPNs were estimated for the three exposure scenarios with the highest potential for release to the environment, including a consumer release scenario resulting from the use of products available to consumers, such as paints and coatings, adhesives and sealants, personal care and cosmetic products, household cleaners, and automotive care products; a generic formulation scenario for products available to consumers and industrial applications; and a pulp and paper scenario for the use of processing aids by pulp and paper mills. Environmental concentrations in the aquatic environment following wastewater treatment associated with releases from these uses were estimated and compared to modelled predicted no effect concentrations on the basis of the predicted composition of LBPNs in the effluent. In addition, the concentration of LBPNs in soils following the application of biosolids from wastewater treatment facilities to soil were compared to predicted no effect concentrations for soil organisms. On the basis of these comparisons, LBPNs are considered unlikely to be causing ecological harm to aquatic and soil organisms. Because of the volatile nature of LBPNs, terrestrial wildlife may be exposed to LBPNs through inhalation. Comparison of a critical toxicity value and estimated annual emission rate of LBPNs to air in this assessment with those in previous assessments on petroleum site-restricted and industry-restricted LBPNs indicates that the LBPNs examined in this assessment are unlikely to be causing ecological harm to terrestrial wildlife.
The potential for cumulative effects was considered in this assessment by examining cumulative exposures from within the group of Petroleum LBPNs. Considering all available lines of evidence presented in this draft assessment, there is a low risk of harm to the environment from the 27 LBPNs in this assessment. It is proposed to conclude that the 27 LBPNs in this assessment do not meet the criteria under paragraph 64(a) or (b) of CEPA, as they are not entering the environment in a quantity or concentration or under conditions that have or may have an immediate or long-term harmful effect on the environment or its biological diversity or that constitute or may constitute a danger to the environment on which life depends.
A critical health effect for the LBPNs was initially considered to be genotoxicity or carcinogenicity of benzene. However, the LBPNs in this assessment contain less than 0.1% benzene according to available data; therefore, concerns associated with benzene genotoxicity or carcinogenicity are not considered applicable, and other critical effects were taken into consideration.
For subgroup 1, the C9–C14 hydrocarbon solvents, chronic neurotoxicity effects on humans and developmental neurotoxicity effects on laboratory animals were identified in inhalation studies. These effects were considered applicable to long-term and short-term exposure inhalation scenarios, respectively. With respect to the dermal route, effects on the peripheral nerve system in laboratory animals were considered to be critical effects following short- and long-term exposure. A comparison of the critical effects levels with the estimated exposures from certain cosmetics and other products available to consumers in Canada resulted in margins of exposure (MOEs) that are considered to be potentially inadequate to address uncertainties in the health effects and exposure databases. On the basis of the estimated maximum environmental media exposures (air and water) of these substances, the risk to human health from exposure to these subgroup 1 substances was considered to be low.
For subgroup 2, the C9 aromatic hydrocarbon solvents, reduced body weights, dose-related mortality in maternal animals, reduced fetal body weights, and delayed ossification in their offspring animals were identified in inhalation studies conducted on laboratory animals. These effects were considered applicable for both short-term and long-term exposure scenarios. With respect to the oral route, effects on the liver and kidneys were considered to be critical effects following long-term exposure. A comparison of the estimated exposures from certain cosmetics and other products available to consumers, including nail polish, nail adhesive, spray paint, stain, floor polish, and lacquer, to the critical effect levels resulted in MOEs that are considered to be potentially inadequate. On the basis of the estimated maximum environmental media exposures (air and water) of these substances, the risk to human health from exposure to these subgroup 2 substances was considered to be low.
For subgroup 3, the C6–C9 aliphatic hydrocarbon solvents, limited health effects data were available for these substances; therefore, toxicological data from representative UVCBs were used to inform the health effects assessment. A reproductive and developmental toxicity endpoint identified in laboratory animals was considered applicable for short-duration exposures, while long-term exposures were compared to a carcinogenicity study in mice. A comparison of the estimated exposures from certain products available to consumers in Canada to the critical effect levels resulted in MOEs that are considered to be potentially inadequate. On the basis of the estimated maximum environmental media exposures (air and water) of these substances, the risk to human health from exposure to these subgroup 3 substances was considered to be low.
The health effects associated with subgroup 4, the LBPNs with no identified uses in products available to consumers, were characterized in a similar fashion to the previous three groupings. On the basis of the estimated maximum environmental media exposures (air and water) of these substances, the risk to human health from exposure to these substances was considered to be low.
The human health assessment took into consideration those groups of individuals within the Canadian population who, due to greater susceptibility or greater exposure, may be more vulnerable to experiencing adverse health effects. In addition, the potential for elevated exposure for people living near non-petroleum industrial facilities that may release some of these substances was considered in the assessment. The potential for cumulative effects was considered in this assessment by examining cumulative exposures from within the groups of Petroleum LBPNs.
Considering all of the information presented in this draft assessment, it is proposed to conclude that the nine C9–C14 hydrocarbon solvents (subgroup 1; CAS RNs 8030-30-6, 8032-32-4, 8052-41-3, 64475-85-0, 64741-41-9, 64741-65-7, 64742-48-9, 64742-82-1, and 64742-88-7), one C9 aromatic solvents (subgroup 2; CAS RN 64742-95-6), and seven C6–C9 aliphatic solvents (subgroup 3; CAS RNs 64741-66-8, 64741-84-0, 64742-49-0, 64742-89-8, 68410-97-9, 68647-60-9, and 426260-76-6), which occur in products available to consumers, meet the criteria under paragraph 64(c) of CEPA, as they are entering or may enter the environment in a quantity or concentration or under conditions that constitute or may constitute a danger in Canada to human life or health. Considering all of the information presented in this draft assessment, it is proposed to conclude that the 10 LBPNs in subgroup 4 with no identified uses in products available to consumers (CAS RNs 64741-68-0, 64741-92-0, 64741-98-6, 68333-81-3, 68512-78-7, 68513-03-1, 68553-14-0, 68603-08-7, 68920-06-9, and 70693-06-0) do not meet the criteria under paragraph 64(c) of CEPA, as they are not entering the environment in a quantity or concentration under conditions that constitute or may constitute a danger in Canada to human life or health.
Proposed overall conclusion
It is therefore proposed to conclude that the 17 LBPNs in C9–C14 hydrocarbon solvents (subgroup 1; CAS RNs 8030-30-6, 8032-32-4, 8052-41-3, 64475-85-0, 64741-41-9, 64741-65-7, 64742-48-9, 64742-82-1, and 64742-88-7), C9 aromatic solvents (subgroup 2; CAS RN 64742-95-6) and C6–C9 aliphatic solvents (subgroup 3; CAS RNs 64741-66-8, 64741-84-0, 64742-49-0, 64742-89-8, 68410-97-9, 68647-60-9 and 426260-76-6) meet one or more of the criteria set out in section 64 of CEPA. It is therefore proposed to conclude that the 10 LBPNs in subgroup 4 with no identified uses in products available to consumers (CAS RNs 64741-68-0, 64741-92-0, 64741-98-6, 68333-81-3, 68512-78-7, 68513-03-1, 68553-14-0, 68603-08-7, 68920-06-9, and 70693-06-0) do not meet any of the criteria set out in section 64 of CEPA.
The draft assessment and the risk management scope document for these substances are available on the Canada.ca (Chemical substances) website.
PRIVY COUNCIL OFFICE
Appointment opportunities
We know that our country is stronger — and our government more effective — when decision-makers reflect Canada’s diversity. The Government of Canada has implemented an appointment process that is transparent and merit-based, strives for gender parity, and ensures that Indigenous peoples and minority groups are properly represented in positions of leadership. We continue to search for Canadians who reflect the values that we all embrace: inclusion, honesty, fiscal prudence, and generosity of spirit. Together, we will build a government as diverse as Canada.
We are equally committed to providing a healthy workplace that supports one’s dignity, self-esteem and the ability to work to one’s full potential. With this in mind, all appointees will be expected to take steps to promote and maintain a healthy, respectful and harassment-free work environment.
The Government of Canada is currently seeking applications from diverse and talented Canadians from across the country who are interested in the following positions.
Current opportunities
The following opportunities for appointments to Governor in Council positions are currently open for applications. Every opportunity is open for a minimum of two weeks from the date of posting on the Governor in Council appointments website.
Position | Organization | Closing date |
---|---|---|
Director | Bank of Canada | |
Director | Canada Foundation for Innovation | |
Director | Canada Foundation for Sustainable Development Technology | |
Director | Canada Infrastructure Bank | |
Chairperson | Canada Mortgage and Housing Corporation | |
Director | Canada Mortgage and Housing Corporation | |
President | Canada Mortgage and Housing Corporation | |
Chairperson | Canadian Accessibility Standards Development Organization | |
Director | Canadian Air Transport Security Authority | |
President | Canadian Broadcasting Corporation | |
Director | Canadian Centre on Substance Abuse | |
Director | Canadian Commercial Corporation | |
Commissioner | Canadian Energy Regulator | |
Director | Canadian Energy Regulator | |
Chief Commissioner | Canadian Grain Commission | |
Chief Commissioner | Canadian Human Rights Commission | |
Member | Canadian Institutes of Health Research | |
President | Canadian Institutes of Health Research | |
Chairperson | Canadian Museum for Human Rights | |
President | Canadian Nuclear Safety Commission | |
Director | Canadian Race Relations Foundation | |
Director | Canadian Tourism Commission | |
Chairperson | Canadian Transportation Accident Investigation and Safety Board | |
Member | Copyright Board | |
Director | Export Development Canada | |
Commissioner | First Nations Tax Commission | |
Director (Federal) | Halifax Port Authority | |
Deputy Chairperson and Member, Refugee Appeal Division | Immigration and Refugee Board | |
Member | Independent Advisory Board on Eligibility for Journalism Tax Measures | |
Vice-Chairperson | Independent Advisory Board on Eligibility for Journalism Tax Measures | |
Member | International Pacific Halibut Commission | |
Chairperson | Laurentian Pilotage Authority | |
Commissioner | Law Commission of Canada | |
Parliamentary Librarian | Library of Parliament | |
Chairperson | National Advisory Council on Poverty | |
Member (Children’s Issues) | National Advisory Council on Poverty | |
Chairperson | National Gallery of Canada | |
Chairperson | National Seniors Council | |
Member | National Seniors Council | |
Member | Natural Sciences and Engineering Research Council | |
Canadian Representative | North Atlantic Salmon Conservation Organization | |
Director of Public Prosecutions | Office of the Director of Public Prosecutions | |
Member | Parole Board of Canada | April 16, 2024 |
Clerk of the Senate and Clerk of the Parliaments | Senate | |
Member | Social Sciences and Humanities Research Council | |
Chairperson | Telefilm Canada | |
Member | Telefilm Canada | |
Director | VIA Rail Canada Inc. |